Camp4 Therapeutics (CAMP) Gains from Investment Securities (2023 - 2025)
Camp4 Therapeutics' (CAMP) quarterly Gains from Investment Securities came in at -$191000.0 in Q4 2025, down 152.47% year-on-year from $364000.0 in Q4 2024, and up 46.5% quarter-over-quarter from -$357000.0 in Q3 2025.
Camp4 Therapeutics (CAMP) Gains from Investment Securities (2023 - 2025) Analysis & Trends
Camp4 Therapeutics has disclosed Gains from Investment Securities across 3 years of filings, most recently posting -$191000.0 for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$191000.0, down 152.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$294000.0 (down 150.87% YoY), and the FY2025 annual result was -$258000.0, down 170.88% from the prior year.
- Gains from Investment Securities came in at -$191000.0 for Q4 2025 at Camp4 Therapeutics, up from -$357000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $364000.0 in Q4 2024 to a low of -$1.1 million in Q4 2023.
- The 3-year median for Gains from Investment Securities is $63686.5 (2024), against an average of -$87453.4.
- Across the five-year window, Gains from Investment Securities soared 133.86% in 2024 and plunged 490.71% in 2025, its largest moves.
- Camp4 Therapeutics' Gains from Investment Securities stood at -$1.1 million in 2023, then jumped by 133.86% to $364000.0 in 2024, then tumbled by 152.47% to -$191000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$191000.0 (Q4 2025), -$357000.0 (Q3 2025), and $254000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -191,000.00 |
| Dec 31, 2025 | -191,000.00 |
| Sep 30, 2025 | -357,000.00 |
| Sep 30, 2025 | -357,000.00 |
| Jun 30, 2025 | 254,000.00 |
| Jun 30, 2025 | 254,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 91,373.00 |
| Sep 30, 2024 | 91,373.00 |
| Jun 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 178,000.00 |
| Dec 31, 2023 | -1.08 Mn |
| Dec 31, 2023 | -1.08 Mn |